Astria Therapeutics presented trial data at a congress held in Paris, with Stephan Weidinger leading the presentation on September 3, 2025.
3 reports, 2 independent
Updated Sep 3
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Astria Therapeutics presented trial data at a congress held in Paris, with Stephan Weidinger leading the presentation on September 3, 2025.
Who's involved
What this event is mainly aboutStephan WeidingerParis
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Business WireAstria Therapeutics to Present Initial Data from Phase 1a Trial of STAR-0310 at Upcoming European Academy of Dermatology & Venereology Congress 2025 BOSTON, September 03, 2025--(BUSINESS WIRE)--Astri
- Barchart2 ‘Strong Buy’ Growth Stocks Offering 300% or Higher Upside Small-cap biotech stocks, while lacking the scale and financial stability of larger pharmaceutical giants, often have high growth potential
- Business WireAstria Therapeutics to Present at Upcoming Cantor Global Healthcare Conference BOSTON, August 27, 2025--(BUSINESS WIRE)--Astria Therapeutics, Inc. (Nasdaq:ATXS), a biopharmaceutical company focused o